Pfizer cuts 180 jobs in Ireland

There's bad news for Cork, Ireland today. After an 18-month search, Pfizer announced plans to cut 180 jobs after failing to find a buyer for five manufacturing facilities there. In a statement, the company said all opportunities to find a buyer have been pursued, with no results. "We were initially optimistic that we would find a buyer because there was considerable interest," said Paul Duffy, Pfizer's vice president of manufacturing for Ireland. "Unfortunately, that interest has not translated into a sale." The first layoffs will begin in October and the entire site will be closed by the end of 2009. 

Pfizer is still trying to sell a facility Ringaskiddy, where 300 people are employed. The company is selling the plants because its planned blockbuster torcetrapib failed and the extra manufacturing capacity is no longer needed.

- read this report for more

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

City of Hope and Canadian biotech Biovaxys Technology reported positive animal data for their COVID vaccines that could offer alternatives to mRNA.

4D is adding a trio of executives to spearhead its work in heart, eye and lung diseases as it pushes programs into and through the clinic.

Janssen has sent off its mutation-specific non-small cell lung cancer drug amivantamab to the FDA.